Cyclodextrins for drug delivery

References

• Al Omaria MM, Daraghmeha NH, El-Barghouthib MI, et al. (2009). Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization. J Pharm Biomed Anal, 50, 449–458.
   PubMed Web of Science ®Google Scholar
• Alexanian C, Papademou H, Vertzoni M, Archontaki H, Valsami G. (2008). Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives. J Pharm Pharmacol, 60, 1433–1439.
   PubMed Web of Science ®Google Scholar
• Agüeros M, Ruiz-Gatón L, Vauthier C, et al. (2009). Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel. Eur J Pharm Sci, 38, 405–413.
   PubMed Web of Science ®Google Scholar
• Araújo J, Gonzalez E, Egea MA, Garcia ML, Souto BE. (2009). Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomed Nanotech Biol Med, In Press.
   Web of Science ®Google Scholar
• Arima H, Adachi H, Irie T. K U. (1996). Possible enhancing of the cutaneous permeation of 4-biphenylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment. Chem Pharm Bull, 44, 582–586.
   PubMed Web of Science ®Google Scholar
• Arima H, Kondo T, Irie T, Uekama K. (1992). Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository. J Pharm Sci, 81, 1119–1125.
   PubMed Web of Science ®Google Scholar
• Asai K, Morishita M, Katsuta H, et al. (2002). The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa. Int J Pharm, 246, 25–35.
   PubMed Web of Science ®Google Scholar
• Bellanger N, Perly B. (1992). NMR investigations of the conformations of new cyclodextrin-based amphiphilic transporters for hydrophobic drugs—molecular lollipops. J Mol Struct, 15, 215–226.
   Google Scholar
• Biwer A, Antranikian G, Heinzle E. (2002). Enzymatic production of cyclodextrins. Appl Microbiol Biotechnol, 59, 609–617.
   PubMed Web of Science ®Google Scholar
• Boulmedarat L, Bochot A, Lesieur S, Fattal E. (2005). Evaluation of buccal methyl-beta-cyclodextrin toxicity on human oral epithelial cell culture model. J Pharm Sci, 94, 1300–1309.
   PubMed Web of Science ®Google Scholar
• Brewster ME, Loftsson T. (2007). Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev, 59, 645–666.
   PubMed Web of Science ®Google Scholar
• Cadars S, Foray MF, Gadelle A, Gerbaud G, Bardet M. (2005). High-resolution solid-state 13C NMR study of per(3,6-anhydro)-a-cyclodextrin based polymers and of their chromium complexes. Carbohyr Polym, 61, 88–94.
   Web of Science ®Google Scholar
• Canceill J, Jullien L, Lacombe L, Lehn J-M. (1992). Channel-type molecular-structures. 2. Synthesis of bouquet-shaped molecules based on a beta-cyclodextrin core. Helv Chim Acta, 75, 791–812.
   Web of Science ®Google Scholar
• Carlsson T, Andersson SB. (1991). Smoking substituted containing an inclusion complex of nicotine and a cyclodextrin compound. In EP0506774; PCT INT., W.O. 9109599 (CA 115; 273283).
   Google Scholar
• Carrier RL, Miller LA, Ahmed I. (2007). The utility of cyclodextrins for enhancing oral bioavailability. J Control Release, 123, 78–99.
   PubMed Web of Science ®Google Scholar
• Challa R, Ahuja A, Ali J, Khar RK. (2004). Cyclodextrins in drug delivery: an updated review. Curr Drug Deliv, 1, 351–360.
   PubMedGoogle Scholar
• Cramer F, Saenger W, Satz HC. (1967). Inclusion compounds. ΧΙХ. The formation of inclusion compounds of alpha cyclodextrin in aqueous solutions, thermodynamics and kinetics. J Am Chem Soc, 89, 14–20.
   Web of Science ®Google Scholar
• Daoud-Mahammed S, Couvreur P, Gref R. (2007a). Novel self-assembling nanogels: stability and lyophilisation studies. Int J Pharm, 332, 185–191.
   PubMedGoogle Scholar
• Daoud-Mahammed S, Ringard-Lefebvre C, Razzouq N, et al. (2007b). Spontaneous association of hydrophobized dextran and poly-beta-cyclodextrin into nanoassemblies. Formation and interaction with a hydrophobic drug. J Colloid Interface Sci, 307, 83–93.
   PubMed Web of Science ®Google Scholar
• Davies MN, Wang G, Tucker IG. (1997). Evaluation of hydrocortisone/hydroxypropyl-beta-cyclodextrin solution for ocular delivery. Int J Pharm, 156, 201–209.
   Google Scholar
• Dinge A, Nagarsenker M. (2008). Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity. AAPS PharmSciTech, 9, 349–356.
   PubMed Web of Science ®Google Scholar
• Dubesa A, Degobertb G, Fessib H, Parrot-Lopez H. (2003). Synthesis and characterisation of sulfated amphiphilic α-, β- and γ-cyclodextrins: application to the complexation of acyclovir. Carbohydr Res, 338, 2185–2193.
   PubMed Web of Science ®Google Scholar
• Duchene D, Bochot A, Loftsson T. (2009). Les cyclodextrines et leurs utilisations en pharmacie et cosmétologie. STP Pharma Pratiques, 19, 15–27.
   Google Scholar
• Duchene D, Wouessidjewe D, Ponchel G. (1999). Cyclodextrins and carrier systems. J Control Release, 62, 263–268.
   PubMed Web of Science ®Google Scholar
• Fahr A, Liu X. (2007). Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv, 4, 403–416.
   PubMed Web of Science ®Google Scholar
• French D. (1957). The Schardinger dextrins. Adv Carbohydr Chem, 12, 189–260.
   PubMed Web of Science ®Google Scholar
• Freundenberg K, Cramer F, Plieninger H. (1953). Inclusion compounds of physiologically active organic compounds. German Patent 895769.
   Google Scholar
• Fridriksdottir H, Loftsson T, Stefánsson E. (1997). Formulation and testing of methazolamide cyclodextrin eye drop solutions. J Controlled Release, 44, 95–99.
   Web of Science ®Google Scholar
• Frijlink HW, Paiotti S, Eissens AC, Lerk CF. (1992). The effects of cyclodextrins on drug release from fatty suppository bases III. Applications of cyclodextrin derivatives. Eur J Pharm Biopharm, 38, 174–179.
   Web of Science ®Google Scholar
• Gaspar de Araújo MV, Barbosa Vieira EK, Silva Lázaro G, et al. (2008). Sulfadiazine/hydroxypropyl-β-cyclodextrin host-guest system: characterization, phase-solubility and molecular modelling. Bioorg Med Chem, 16, 5788–5794.
   PubMed Web of Science ®Google Scholar
• Gerlóczy A, Fónagy A, Keresztes P, Perlaky L, Szejtli J. (1985). Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat. Arzneimittelforschung, 35, 1042–1047.
   PubMed Web of Science ®Google Scholar
• Gireka T, Kozlowskia CA, Koziola JJ, Walkowiakb W, Korusc I. (2005). Polymerisation of b-cyclodextrin with succinic anhydride. Synthesis, characterisation, and ion flotation of transition metals. Carbohydr Polym, 59, 211–215.
   Web of Science ®Google Scholar
• Gould S, Scott RC. (2005). 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. Food Chem Toxicol, 43, 1451–1459.
   PubMed Web of Science ®Google Scholar
• Granero GE, Maitre MM, Garnero C, Longhi MR. (2008). Synthesis, characterization and in vitro release studies of a new acetazolamide-HP-beta-CD-TEA inclusion complex. Eur J Med Chem, 43, 464–470.
   PubMed Web of Science ®Google Scholar
• Gref R, Amiel C, Molinard K, et al. (2006). New self-assembled nanogels based on host-guest interactions: characterization and drug loading. J Control Release, 111, 316–324.
   PubMed Web of Science ®Google Scholar
• Haeberlin B, Gengenbacher T, Meinzer A, G., F. (1996). Cyclodextrins—useful excipients for oral peptide administration. Int J Pharm, 137, 103–110.
   Web of Science ®Google Scholar
• Hamilton RM, Healy RE. (1970). Eliminating undesirable taste from coffee and tea extracts and products, by treatment with a cyclodextrin. US33528819 (C.A. 74:12014).
   Google Scholar
• Hermes WAJJ, Belder CWJ, Merkus JMWM, Hooymans PM, Verhoef J, Merkus FWHM. (1992). Intranasal administration of estradiol in combination with progesterone to oophorectomized women: a pilot study. Eur J Obstet Gynecol Reprod Biol, 43, 65.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors KA. (1965). Phase-solubility techniques. Adva Anal Chem Instr 4, 212–217.
   Google Scholar
• Hirano K, Ishihara T, Ogasawara S, et al. (2005). Molecular cloning and characterisation of a novel gama-CGTase from alkalophilic Bacillus sp. Appl Microbiol Biotechnol, 67, 1–9.
   PubMedGoogle Scholar
• Iriea T, Wakamatsua K, Arimaa H, Aritomia H, Uekama K. (1992). Enhancing effects of cyclodextrins on nasal adsorption of insulin in rats. Int J Pharm, 84, 129–139.
   Google Scholar
• Jansook P, Loftsson T. (2008). gammaCD/HPgammaCD: synergistic solubilization. Int J Pharm, 363, 217–219.
   PubMed Web of Science ®Google Scholar
• Jarho P, Jarvinen K, Urtti A, Stella VJ, Jarvinen T. (1997). The use of cyclodextrins of ophtalmic formulations of dipivefrin. Int J Pharm, 153, 225–233.
   Google Scholar
• Järvinen K, Järvinen T, Thompson DO, Stella VJ. (1994). The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine. Curr Eye Res, 13, 897–905.
   PubMed Web of Science ®Google Scholar
• Järvinen K, Järvinen T, Urtti A. (1995). Ocular absorption following topical delivery. Adv Drug Deliv Rev, 16, 3–19.
   Web of Science ®Google Scholar
• Kaji Y, Uekama K, Yoshikawa H, Takada K, Muranishi S. (1985). Selective transfer of 1- hexylcarbamoyl-5-fluorouracil into lymphatics by combination of beta-cyclodextrin polymer complexation and absorption promotor in the rat. Int J Pharm, 24, 79–89.
   Web of Science ®Google Scholar
• Kawahara K, Ueda H, Tomono K, Nagai T. (1992). Effect of diethyl beta-cyclodextrin and the release and absorption behaviour of indometacin from ointment bases. STP Pharm Sci, 2, 506–513.
   Google Scholar
• Kikuchi M, Hirayama F, Uekama K. (1987). Improvement of oral and rectal bioavailabilities of carmofur by methylated beta-cyclodextrin complexations. Int J Pharm, 38, 191–198.
   Google Scholar
• Koizumi K, Okada Y, Kubota Y, Utamuta T. (1987). Inclusion complexes of poorly water-soluble drugs with glucosyl-cyclodextrins. Chem Pharm Bull, 35, 3416.
   Google Scholar
• Kondo T, Irie T, Uekama K. (1996a). Effects of cyclodextrin derivatives on systemic absorption of morphine through nasal cavity and entry into central nervous system in rats. Drug Deliv Syst, 11, 99.
   Google Scholar
• Kondo T, Irie T, Uekama K. (1996b). Combination effects of α-cyclodextrin and xanthan gum on rectal absorption and metabolism of morphine from hollow-type suppositories in rabbits. Biol Pharm Bull, 19, 280–286.
   PubMed Web of Science ®Google Scholar
• Krauland AH, Alonso MJ. (2007). Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int J Pharm, 340, 134–142.
   PubMed Web of Science ®Google Scholar
• Lang JC. (1995). Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev, 16, 39–43.
   Web of Science ®Google Scholar
• Lantz AW, Rodriguez MA, Wetterer SM, Armstrong DW. (2006). Estimation of association constants between oral malodor components and various native and derivatized cyclodextrins. Anal Chim Acta, 557, 184–190.
   Web of Science ®Google Scholar
• Legendre JY, Rault I, Petit A, et al. (1995). Effects of beta-cyclodextrins on skin: implications for the transdermal delivery of piribedil and a novel cognoition enhancing-drug, S-9977. Eur J Pharm Sci, 3, 311–322.
   Web of Science ®Google Scholar
• Lin J. (1995). Synthèse des cyclodextrins amphiphiles et étude de leur incorporation dans des phases phospholipidiques. Thesis, Université de Paris VI.
   Google Scholar
• Ling W, Xuehuab J, Weijuan X, Chenrui L. (2007). Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats. Int J Pharm, 341, 58–67.
   PubMedGoogle Scholar
• Lister RE, Acerbi D, Cadel S. (1993). Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals. Eur J Rheumatol Inflamm, 12, 6–11.
   PubMedGoogle Scholar
• Loftsson T & Frioriksdottir H. (1998). The effect of water-soluble polymers on the aqueous solubility and complexing abilities of beta-cyclodextrin. Int J Pharm, 163, 115–121.
   Web of Science ®Google Scholar
• Loftsson T, Järvinen T. (1999). Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev, 36, 59–79.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Stefánsson E. (2002). Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol Scand, 80, 144–150.
   PubMedGoogle Scholar
• Loftsson T, Gudmundsdóttir H, Sigurjónsdóttir JF, et al. (2001). Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm, 212, 29–40.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Matthíasson K, Másson M. (2003). The effects of organic salts on the cyclodextrin solubilization of drugs. Int J Pharm, 262, 101–107.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Jarho P, Másson M, Järvinen T. (2005). Cyclodextrins in drug delivery. Expert Opin Drug Deliv, 2, 335–351.
   PubMed Web of Science ®Google Scholar
• Lopez RFV, Collet JH, Bentley MVLB. (2000). Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int J Pharm, 200, 127–132.
   PubMed Web of Science ®Google Scholar
• Maestrellia F, González-Rodríguezb ML, Rabascob AM, Muraa P. (2006a). Effect of preparation technique on the properties of liposomes encapsulating ketoprofen–cyclodextrin complexes aimed for transdermal delivery. Int J Pharm, 312, 53–60.
   PubMedGoogle Scholar
• Maestrellia F, Garcia-Fuentes M, Mura P, Alonso MJ. (2006b). A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin. Eur J Pharm Biopharm, 63, 79–86.
   PubMed Web of Science ®Google Scholar
• Mallick S, Pattnaik S, Swain K, De PK. (2007). Current perspectives of solubilization: potential for improved bioavailability. Drug Dev Ind Pharm, 33, 865–873.
   PubMed Web of Science ®Google Scholar
• Martel B, Ruffin D, Weltrowski M, Lekchiri Y, Morcellet M. (2005). Water-soluble polymers and gels from the polycondensation between cyclodextrins and poly(carboxylic acid)s: a study of the preparation parameters. J Appl Polym Sci, 97, 433–442.
   Web of Science ®Google Scholar
• Masahikoa K, Fumitoshia H, Kaneto U. (1987). Improvement of oral and rectal bioavailabilities of carmofur by methylated β-cyclodextrin complexations. Int J Pharm, 38, 191–198.
   Google Scholar
• Matsuda H, Arima H. (1999). Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliv Rev, 36, 81–99.
   PubMed Web of Science ®Google Scholar
• McCormack B, Gregoriadis G. (1994). Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery. Int J Pharm, 112, 249–258.
   Web of Science ®Google Scholar
• Memisoglu-Bilensoy E, Hincal AA, Bochot A, Trichard L, Duchene D, eds. (2006). Amphiphilic cyclodextrins and microencapsulation. In: Microencapsulation, 2nd and revised edition. Benita S. (ed.). New York: Taylor & Francis Ltd.
   Google Scholar
• Miro A, Rondinone A, Nappi A, Ungaro F, Quaglia F, La Rotonda M. (2009). Modulation of release rate and barrier transport of Diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery. Eur J Pharm Biopharm, 72, 76–82.
   PubMed Web of Science ®Google Scholar
• Monza Da Silveira A, Ponchel G, Duchene D, Couvreur P, Puisieux F. (1999). Nanoparticles comprising polyisobutylcyanoacrylate and cuclodextrins. France, WO 99/43359.
   Google Scholar
• Nagarwala RC, Kantb S, Singha PN, Maitic P, Pandita JK. (2009). Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release, 136, 2–13.
   PubMed Web of Science ®Google Scholar
• Okamoto H, Komatsu H, Hashida M, Sezaki H. (1986). Effects of β-cyclodextrin and di-O-methyl-β-cyclodextrin on the percutaneous absorption of butylparaben, indomethacin and sulfanilic acid. Int J Pharm, 30(1), 35–45.
   Google Scholar
• Otagiri M, Fujinaga T, Sakai A, Uekama K. (1984). Effects of beta-cyclodextrin and gama-cyclodextrins on release of betamethasone from ointment bases. Chem Pharm Bull, 32, 2401–2405.
   PubMed Web of Science ®Google Scholar
• Palma SD, Tartara LI, Quinteros D, Allemandi DA, Longhi MR, Granero GE. (2009). An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration. J Control Release, 138, 24–31.
   PubMed Web of Science ®Google Scholar
• Patel SG, Rajput SJ. (2009). Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. Eur J Pharm Biopharm, 73, 202–204.
   PubMedGoogle Scholar
• Perrin JH, Field FP, Hansen DA, Mufson RA, Torosian G. (1978). beta-Cyclodextrin as an aid to peritoneal dialysis. Renal toxicity of beta-cyclodextrin in the rat. Res Commun Chem Pathol Pharmacol, 19, 373–376.
   PubMedGoogle Scholar
• Phillip Lee YH, Sathigari S, Jean Lin YJ, et al. (2009). Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies. Drug Dev Ind Pharm, 35, 1113–1120.
   PubMed Web of Science ®Google Scholar
• Qi Q, Mokhtar MN, Zimmermann W. (2007). Effect of ethanol on the synthesis of large-ring cyclodextrins by cyclodextrin glucanotransferases. J Incl Phenom Macrocycl Chem, 57, 95–99.
   Web of Science ®Google Scholar
• Rahman AAA, Khidr SH, Ahmed SM, Aboutaleb AE. (1991). Evaluation of chloramphenicol-beta-cyclodextrin inclusion complex. Eur J Pharm Biopharm, 37, 34–37.
   Web of Science ®Google Scholar
• Ren K, Zhang Z, Li Y, et al. (2009). Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin. Pharmazie, 64, 515–520.
   PubMed Web of Science ®Google Scholar
• Renard E, Deratani A, Volet G, Sebille B. (1997). Preparation and characterisation of water soluble high molecular weight beta-cyclodextrin–epichlorohydrin polymers. Eur Polym J, 33, 49–57.
   Web of Science ®Google Scholar
• Rezende BA, Cortes SF, De Sousa FB, et al. (2009). Complexation with beta-cyclodextrin confers oral activity on the flavonoid dioclein. Int J Pharm, 367, 133–139.
   PubMed Web of Science ®Google Scholar
• Ritter H, Tabatabai M. (2002). Cyclodextrin in polymer synthesis: a green way to polymers. Prog Polym Sci, 27, 1713–1720.
   Web of Science ®Google Scholar
• Sathigari S, Chadha G, Lee YH, et al. (2009). Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes. AAPS PharmSciTech, 10, 81–87.
   PubMed Web of Science ®Google Scholar
• Schardinger F. (1903). Uber thermophile Backterien aus verschiedenen Speisen und Milch, sowie uber einige Umsetzungsprodukte derselben in kohenhydrathaltigen Nahrlosungen, darunter krystallisierte Polysacaccharide (Dextrine) aus Starke. Z Untersuch Nahr u Genussm, 6, 865.
   Google Scholar
• Shimpi S, Chauhan B, Shimpi P. (2004). Cyclodextrins: application in different routes of drug administration. Pharm Res, 21, 201–230.
   PubMedGoogle Scholar
• Siguroardottir MA, Loftsson T. (1995). The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion throught hairless mouse skin. Int J Pharm, 126, 73–78.
   Web of Science ®Google Scholar
• Sjejtli J, Szente L. (2005). Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm, 61, 115–125.
   PubMed Web of Science ®Google Scholar
• Soares AF, Carvalho RdeA, Veiga F. (2007). Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems. Nanomed, 2, 183–202.
   PubMed Web of Science ®Google Scholar
• Songa LX, Baia L, Xub MX, Hea J, Pana SZ. (2009). Inclusion complexation, encapsulation interaction and inclusion number in cyclodextrin chemistry. Coord Chem Rev, 253, 1276–1284.
   Web of Science ®Google Scholar
• Stella VJ, He Q. (2008). Cyclodextrins. Toxicol Pathol, 36, 30–42.
   PubMed Web of Science ®Google Scholar
• Stickley RG. (1994). Solubilizing excipients in oral and injectable formulations. Med Res Rev, 14, 353–386.
   PubMedGoogle Scholar
• Szejtli J. (1998). Introduction and general overview of cyclodextrin chemistry. Chem Rev, 98, 1743–1754.
   PubMed Web of Science ®Google Scholar
• Szeman J, Ueda H, Szejtli J, et al. (1987). Enhanced percutaneous absorption of homogenized tolnaftate/beta-cyclodextrin polymer ground mixture. Drug Des Deliv, 1, 325–332.
   PubMedGoogle Scholar
• Takada M, Ide T, Yamamoto T, et al. (2003). Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin by using this enzyme. USA Patent 20030194796 A1.
   Google Scholar
• Tenjarla S, Puranajoti P, Kasina R, Mandal T. (1998). Preparation, characterisation and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery. J Pharm Sci, 87, 425–429.
   PubMed Web of Science ®Google Scholar
• Tokumura T, Muraoka A, Machida Y. (2009). Improvement of oral bioavailability of flurbiprofen from flurbiprofen/beta-cyclodextrin inclusion complex by action of cinnarizine. Arch Pharm Res, 32, 155–156.
   PubMedGoogle Scholar
• Uekama K, Irie T, eds. (1987). Industrial uses of methylated cyclodextrins derivatives. In: Cyclodextrins and Their Industrial Uses. Duchene D. (eds). Paris: Editions de Santé.
   Google Scholar
• Valle EMM. (2004). Cyclodextrins and their uses: a review. Process Biochemistry, 39, 1033–1046.
   Web of Science ®Google Scholar
• Villiers A. (1891). Sur la fermetation de la fécule de pommes par l’action du ferment butyrique. Compt Rend Acad Sci, 112, 536.
   Google Scholar
• Watanabe Y, Matsumoto Y, Seki M, Takase M, Matsumoto M. (1992). Absorption enhancement of polypeptide drugs by cyclodextrins.I. Enhanced rectal absorption of insulin from hollow-type suppositoires containing insulin and cyclodextrins in rabbits. Chem Pharm Bull, 40, 3042–3047.
   PubMed Web of Science ®Google Scholar
• Yanagi H, Ishikura N, Kenmotsu H. (1991). Effect of inclusion complexation of decanoic acid with alfa -cyclodextrin on rectal absorption of cefmetazole sodium suppository in rabbits. Yakugaku Zasshi, 111, 65–69.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma PX. (2009). Polymeric core-shell assemblies mediated by host-guest interactions: versatile nanocarriers for drug delivery. Angew Chem Int Ed Engl, 48, 964–968.
   PubMed Web of Science ®Google Scholar
• Zhang P, Ling CC, Coleman AW, Parrot- Lopez H, Galons H. (1991). Formation of amphiphilic cyclodextrins via hydrophobic esterification at the secondary hydroxyl face. Tetrahedron Lett, 32, 2769–2770.
   Web of Science ®Google Scholar
• Zhao D, Zhao L, Zhu C-S, Huang W-Q, Hu J-L. (2009). Water-insoluble b-cyclodextrin polymer crosslinked by citric acid: synthesis and adsorption properties toward phenol and methylene blue. J Incl Phenom Macrocycl Chem, 63, 195–201.
   Web of Science ®Google Scholar
• Zhaofeng L, Miao W, Feng W, et al. (2007). γ-Cyclodextrin: a review on enzymatic production and applications. Appl Microbiol Biotechnol, 77, 245–255.
   PubMed Web of Science ®Google Scholar